Ann: New Pre-Clinical Collaboration on PAT-DX1, page-18

Yes, probably, hopefully, what we'll get in the "Dynamics" announcement at the end of May.
I guarantee that not many instos or S.I.s understand what PAB are even doing. Maybe many on HC even?
IMO, that's half the problem why people haven't seen the potential value of this company.
They have been talking to a very minor portion of the investment and biotech market with extremely specialized and technical jargon. How often do we see that? Investors hate uncertainty, so, how do we expect them to invest their hard earned when they wouldn't understand what they are getting into.
The media release on 19 March, despite the potential ramifications, was a classic case in question and it went over most people's head. SP soared to 7.6 and straight back down again. Nothing's changed with the result!